← FDA Drug Approvals (Drugs@FDA)
EPINEPHRINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: DIFGEN PHARMS · Approved 2026-09-15
Drug application
- FDA Application #
ANDA220657- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- EPINEPHRINE
- Generic name
- Epinephrine
- Active ingredients
- EPINEPHRINE
- Dosage form
- SOLUTION
- Route
- INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
- Marketing status
- Prescription
- Sponsor
- DIFGEN PHARMS
- First approval
- 2026-09-15
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown